Acute administration of systemic vasodilating drugs has been shown to improve the haemodynamic status of patients in congestive heart failure, with and without acute myocardial infarction (Miller et al., 1975; Flaherty et al., 1975; Shell and Sobel, 1974; Walinsky et al., 1974) . The nitrates and phentolamine have in fact been effective in some patients refractory to conventional therapy (Guiha et al., 1974; Gold, Leinbach, and Sanders, 1972; Majid, Sharma, and Taylor, 1971) .
Most studies to date have used potent, rapid acting intravenous preparations of sodium nitroprusside, nitroglycerin, phentolamine, or trimethaphan. These require intensive haemodynamic monitoring and precise control of infusion rates to avoid induction of dangerous systemic hypotension (Guiha et al., 1974; Walinsky et al., 1974) . This manner of administration is necessarily restricted to the intensive care setting. More general clinical applicability would require a long-acting vasodilator preparation suitable for administration without intravenous infusion or frequent haemodynamic monitoring. Oral nitrate preparations have been proposed for this purpose Received 24 February 1976. 'Supported in part by grants from the Southeastern Pennsylvania Heart Association. Presented in part at the 25th annual Scientific Session of the American College of Cardiology, 26 February 1976 . Kasparian et al., 1975 , but controversy persists regarding their efficacy and resistance to rapid hepatic transformation (Goldstein et al., 1971; Needleman, Lang, and Johnson, 1972) .
Cutaneously administered nitroglycerin has the theoretical advantage of enhanced bioavailability because of direct absorption into the systemic circulation. It is similar in this regard to sublingual and intravenous preparations whose activity is readily seen but of brief duration (Goldstein et al., 1971; Goldstein and Epstein, 1973; Klaus et al., 1973) . The cutaneous route might provide sustained activity on the basis of continuous absorption from a sizeable depot on the skin. In this connexion, nitroglycerin ointment has recently been shown to improve exercise tolerance in angina pectoris patients for at least 3 hours (Reichek et al., 1974) .
The present study was undertaken to determine whether nitroglycerin ointment causes nitrate-like haemodynamic effects of sufficient magnitude and duration to be of potential value in therapy of congestive heart failure.
Methods
Eleven consecutive patients clinically suspected of having significant left ventricular dysfunction, and found to have pulmonary wedge pressures greater .,~~~~, , ,
SSP SDP from control for all values are listed in Table 2 and illustrated in Fig. 1 . Pulmonary wedge pressure was significantly reduced by 7-9 nunHg at 15 minutes (P <0-005). Maximum reductions of 12-9 mmHg and 15-8 nunHg occurred at 4 and 5 hours, respectively (P < 0-005 for both).
Similary, pulmonary artery pressure was significantly reduced by 7-3 mmHg (P <0-005) at 15 minutes. Peak reductions were 12-1 mmHg and 12-9 mmHg at 4 and 5 hours (P < 0-005 and < 0-05).
Systemic systolic pressure was also significantly reduced at 15 minutes by 8-5 mmHg (P < 0-05).
Again, peak effect was observed at 4 and 5 hours when reductions were 17-7 mmHg and 19-8 nunHg, respectively (P <0-005 and <0-025).
The reduction in systemic diastolic pressure was not significant until 30 minutes and was 9-0 mmHg (P < 0-025) at that time. Again, peak reductions of 10-5 mmHg and 13-5 mmHg were noted at 4 and 5 hours (P < 0-005 and < 0-05, respectively).
Five of six patients showed return of haemodynamic levels toward normal within one hour of removal of nitroglycerin ointment.
Although no attempt was made to quantify symptoms or physical signs, 4 patients who were dyspnoeic during the control period had relief of *** *** *** *** *** ***~~~~~~~~** PWP (mmHg) -7-9±1-5 -10-6±2-3 -9-0±2-4 -12-5 +2-4 -12-7±1-8 -12-9±1-7 -15-8 ±3-3 PAP (mmHg) -7-3 +1-5 -9-6+2-5 -9-4+2-9 -12-8±2-1 Abbreviations: PWP, pulmonary wedge pressure; PAP, pulmonary arterial mean pressure; SSP, systemic arterial systolic pressure; SDP, systemic arterial diastolic pressure; HR, heart rate; *=P<0-05; **=P<0-025; ***=P<0)005. Fig. 2 . When nitroglycerin ointment was discontinued for 3 days she regained 1-8 kg.
Weight loss then resumed when nitroglycerin ointment was reinstituted. No patient developed symptoms or physical signs of systemic arterial hypotension during the study. Several patients complained of headache. One patient noted mild burning at the site of 4 per cent nitroglycerin ointment application.
Discussion
The beneficial effects of sublingual or intravenous vasodilating drugs in congestive heart failure have been attributed to simultaneous reduction of left ventricular outflow impedance and filling pressure caused, respectively, by arteriolar and venous vasodilatation. These changes permit the left ventricle to operate at a smaller cavity size with consequently improved mechanical efficiency and reduced myocardial oxygen demand. The observed haemodynamic effects include distinct reduction in pulmonary wedge pressures and modest reduction in systemic arterial pressures without change in heart rate (Miller et al., 1975; Gold et al., 1972; Flaherty et al., 1975; . Cardiac output response is variable and appears to be a function of left ventricular filling pressure (Miller et al., 1975; Gold et al., 1972; Johnson, Fairley, and Carter, 1959; Walinsky et al., 1974; Williams, Amsterdam, and Mason, 1975 For the purpose of this study, reduction of pulmonary wedge pressure was used as an objective indicator of drug effectiveness. Our experience suggests that for routine use it would be sufficient to monitor systemic blood pressure while increasing the dose and application area until a satisfactory clinical response is observed. In this connexion, 3 of our study patients who were symptomatic and poorly responsive to conventional therapy for congestive heart failure were maintained on nitroglycerin ointment after the study. All reported improvement in their congestive symptoms, and untoward effects other than headaches were not observed. The clinical course in one patient with biventricular failure and anasarca has been described above and in Fig. 2 .
The sustained haemodynamic activity observed in our study suggests that nitroglycerin ointment may prove applicable to other disease states for which vasodilator therapy is appropriate, such as in prophylaxis of angina pectoris. Though this study did not deal specifically with angina, our demonstration of sustained pharmacological activity is consistent with the exercise studies of Reichek et al. (1974) .
Recent studies in both experimental animals and man suggest that vasodilator therapy during acute myocardial infarction may limit the extent and sequelae of myocardial necrosis (Flaherty et al., 1975; Shell and Sobel, 1974; Smith et al., 1973; Borer et al., 1974) . If future investigations confirm these findings, nitroglycerin ointment may provide a convenient means of reducing myocardial oxygen demand in routine management of acute myocardial infarction.
In summary, our data indicate that nitroglycerin ointment causes a sustained haemodynamic response similar to that seen with acutely administered vasodilators. With careful adjustment of dosage and application area it can be used in ambulatory patients without induction of dangerous hypotension. Accordingly, it has potential value in chronic vasodilator therapy of congestive heart failure and merits consideration for use in other clinical situations for which sustained vasodilatation is appropriate.
